Skip to main content

Table 1 Characteristics of survivors and non-survivors

From: The moderate predictive value of serial serum CRP and PCT levels for the prognosis of hospitalized community-acquired pneumonia

 

All patients (%)

n=350

Survivors (%)

n=312

Non-Survivors (%)

n=38

P value

Age(years)

58.53±19.1

58.59±19.2

58.03±18.9

0.86

Males

204 (58.3)

181(58.0)

23(60.5)

0.7

Comorbidity

 Diabetes Mellitus

30(8.57)

27(8.6)

3(7.8)

0.87

 Chronic heart disease

100(28.57)

91(29.1)

9(23.6)

0.48

 Chronic liver disease

22(6.29)

20(6.4)

2(5.2)

0.78

 Chronic renal disease

47(13.43)

40(12.8)

7(18.4)

0.34

 Malignant disease

26(7.43)

24(7.6)

2(5.2)

0.59

 History of Shock

17(4.86)

15(4.8)

2(5.2)

0.9

 COPD

22(6.29)

18(5.7)

4(10.5)

0.25

 Cerebrovascular disease

39(11.14)

35(11.2)

4(10.5)

0.9

 Antimicrobial treatment before admission

79(22.6)

70(22.4)

9(23.7)

1

Signs and symptoms

 Cough

268(76.6)

260(83.3)

28(73.6)

0.14

 Chest pain

116(33.1)

106(33.9)

10(26.3)

0.34

 Expectoration

168(48)

148(47.4)

20(52.6)

0.54

 Dyspnea

249(71.1)

221(70.8)

28(73.6)

0.72

 Chills

124(35.4)

109(34.9)

15(39.4)

0.58

 Headaches

75(21.4)

58(18.5)

17(44.7)

<0.001

 Myalgia

79(22.6)

71(22.7)

8(21)

0.8

 Crackles

114(32.6)

102(32.6)

12(31.5)

0.89

 Fever

110(31.4)

96(30.7)

14(36.8)

0.45

 Confusion

5(1.4)

1(0.3)

4(10.5)

<0.001

CCI class

 0-2

129(36.8)

116(37.1)

13(34.2)

0.7

 3-5

180(51.4)

161(51.6)

19(50)

 

 >5

41(11.7)

35(11.2)

6(15.7)

 

 CRP1 (mg/L)

65.3±84.7

66.3±85.2

57.1±81.3

0.53

 CRP3 (mg/L)

56.4±77.4

50±66.4

109.1±128.4

<0.001

 CRP3c

556.6±5056.3

575.2±5334.2

401.2±1242.4

0.843

 CRP3c<0

223(63.7)

214(68.5)

9(23.6)

<0.001

 CRP5(mg/L)

44.8±68.5

37.9±61

102.1±96.9

<0.001

 CRP5c

429.2±3489.6

429.2±3670.1

429.3±1207.6

0.999

 CRP5c<0

222(63.4)

213(68.2)

9(23.6)

<0.001

 PCT1 (ng/mL)

1.8±7.1

1.8±7.3

1.9±5.5

0.96

 PCT3 (ng/mL)

1.7±6.3

1.4±4.4

4.1±14.5

0.012

 PCT3c

791.2±2653.8

793.3±2672.6

774.1±2528.7

0.966

 PCT3c<0

174(49.7)

157(50.3)

17(44.7)

0.52

 PCT5 (ng/mL)

1.2±3.7

0.8±2

4.3±9.3

<0.001

 PCT5c

695.3±2463

589.9±2298.2

1555±3454.4

0.022

 PCT5c<0

179(51.1)

170(54.4)

9(23.6)

<0.001

 WBC1

10.4±8

10.1±7.2

12.6±12.8

0.081

 WBC3

9.5±5

9.2±5

10.8±4.7

0.112

 WBC5

10.5±6.6

10.4±7

10.6±4.7

0.932

CURB class

 0-2

289

256

33

0.46

 3-5

61

56

5

 
  1. Data are presented as means \( \overline{x} \) ±SD, or n (%), CRP, C-reactive protein; CURB-65, confusion, urea > 7 mmol/L, respiratory rate≥30 breaths/min, low blood pressure (systolic<90mm Hg or diastolic≤60 mm Hg) and age≥65 years
  2. PCT procalcitonin, COPD Chronic Obstructive Pulmonary Disease, SD standard deviation, WBC white blood cell, CRP3c 5c: CRP clearance on day3, day5 PCT3c, 5c PCT clearance on day 3, day 5